Lv7
4540 积分 2023-11-30 加入
Comparison of neoadjuvant chemoimmunotherapy with or without concurrent radiotherapy for locally advanced resectable esophageal squamous cell carcinoma: a multicenter retrospective study
9天前
已完结
Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma
9天前
已关闭
Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2-3 Esophageal Squamous Cell Carcinoma
9天前
已关闭
Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma
1个月前
已完结
Collateral Lymphatico-Venous Communications After Experimental Obstruction of the Thoracic Duct
2个月前
已完结
The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
2个月前
已完结
Can combined organ resection cure T4 esophageal cancer? Insights from a multi-institutional study of incomplete resection cases
2个月前
已完结
Survival After Pathological Complete Response Following Neoadjuvant Chemotherapy vs Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
2个月前
已完结
Preoperative Circulating Tumor DNA Detection and Risk Stratification in Esophageal Squamous Cell Carcinoma
2个月前
已完结
Establishing a standard surgery for esophagogastric junction cancer: Final results from the JGCA-JES nationwide prospective study
2个月前
已完结
皖公网安备34019202002308
